Page last updated: 2024-10-24

S-nitrosoglutathione reductase (NADH) activity

Definition

Target type: molecularfunction

Catalysis of the reaction: S-nitrosoglutathione + NADH + H+ = S-(hydroxysulfenamide)glutathione + NAD+. [PMID:11260719, PMID:27094420, PMID:30795534]

S-nitrosoglutathione reductase (NADH) activity catalyzes the reduction of S-nitrosoglutathione (GSNO) to glutathione (GSH) and nitric oxide (NO). This reaction is important for maintaining cellular redox homeostasis and regulating NO signaling. The enzyme utilizes NADH as a cofactor to transfer electrons to GSNO, resulting in the cleavage of the S-N bond and the release of NO. This activity plays a crucial role in various cellular processes, including: 1) detoxification of reactive nitrogen species, such as GSNO, which can cause oxidative stress and damage cellular components. 2) regulation of NO signaling pathways, as the enzyme can modulate NO levels in cells. 3) control of protein S-nitrosylation, a post-translational modification that regulates protein function. 4) modulation of cellular redox state, as the enzyme contributes to the balance between reduced and oxidized glutathione. 5) regulation of vasodilation and blood pressure, as NO is a potent vasodilator. S-nitrosoglutathione reductase (NADH) activity is a key enzyme in the cellular response to oxidative stress and NO signaling, and its dysregulation is implicated in various diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Aldo-keto reductase family 1 member A1An aldo-keto reductase family 1 member A1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14550]Homo sapiens (human)

Compounds (12)

CompoundDefinitionClassesRoles
zopolrestatzopolrestat: structure given in first source
valproic acidvalproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
branched-chain fatty acid;
branched-chain saturated fatty acid
anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
fr 74366
tolrestattolrestat: RN & structure given in first sourcenaphthalenesEC 1.1.1.21 (aldehyde reductase) inhibitor
octyl gallategallate esterfood antioxidant;
hypoglycemic agent;
plant metabolite
lidorestatlidorestat: might prove useful in treating chronic diabetic complications; structure in first source
fidarestatfidarestat: structure given in first source
minalrestatminalrestat: a vasoactive agentisoquinolines
sorbinilsorbinil : An azaspiro compound having a monofluoro-substituted chromane skeleton spiro-linked to an imidazolidinedione ring.

sorbinil: aldose reductase inhibitor
azaspiro compound;
chromanes;
imidazolidinone;
organofluorine compound;
oxaspiro compound
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor
epalrestatepalrestat : A monocarboxylic acid that is 1,3-thiazolidine which is substituted on the nitrogen by a carboxymethyl group, at positions 2 and 4 by thioxo and oxo groups, respectively, and at position 5 by a 2-methyl-3-phenylprop-2-en-1-ylidene group. It is an inhibitor of aldose reductase (which catalyses the conversion of glucose to sorbitol) and is used for the treatment of some diabetic complications, including neuropathy.monocarboxylic acid;
thiazolidines
EC 1.1.1.21 (aldehyde reductase) inhibitor
idd 594Idd 594: structure in first source
caffeic acid phenethyl esterphenethyl caffeate : An alkyl caffeate ester in which 2-phenylethyl is the alkyl component.alkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent